-
UNPARALLELED SCALABILITY
10x increase in productivity compared with conventional CDMOs
-
COST SAVINGS
Up to 50% lower price per batch compared with conventional CDMOs
-
QUALITY
75% lower process failure rates compared with conventional CDMOs
-
Smart Factory
South San Francisco, CA - Preclinical & Clinical Services / Technology Development
- 57,000 Sq Ft
-
Smart Factory
South San Francisco, CA - Preclinical & Clinical Services / Technology Development
- 57,000 Sq Ft
-
Smart Factory
Bridgewater, NJ - Preclinical, Clinical & Commercial Services
- 118,000 Sq Ft
-
Smart Factory
Bridgewater, NJ - Preclinical, Clinical & Commercial Services
- 118,000 Sq Ft
-
Smart Factory - Europe
COMING SOON - Preclinical, Clinical & Commercial Services
-
Smart Factory - Europe
COMING SOON - Preclinical, Clinical & Commercial Services
-
Smart Factory - Asia
COMING SOON - Preclinical, Clinical & Commercial Services
-
Smart Factory - Asia
COMING SOON - Preclinical, Clinical & Commercial Services
- Existing Smart Factories
- Planned Smart Factories
- Manufacturing Services
-
- Advanced Technology
-
Scalability
10x increase in productivity
-
Cost Savings
Up to 50% reduction in cost per batch
-
QUALITY
Reduction in process failure rates
-
FLEXIBILITY
Majority of cell therapy modalities supported
Careers
Do What’s Never Been Done Before
Cellares is always looking for passionate and world-class professionals to join our interdisciplinary team
-
November 12, 2024
Cellares Appoints Ossama Eissa, Former Novartis, Lonza, and Legend Biopharma Leader as Chief Operating Officer
-
September 12, 2024
Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform
-
September 05, 2024
Cellares Announces Completion of First cGMP Cell Shuttle at IDMO Smart Factory in Bridgewater, New Jersey